Literature DB >> 8808873

Racial differences in a prostate cancer screening study.

D S Smith1, A D Bullock, W J Catalona, J D Herschman.   

Abstract

PURPOSE: We attempted to determine whether black men have a higher prostate cancer prevalence and more advanced disease.
MATERIALS AND METHODS: We screened 17,157 white and 804 black men 50 years old or older by serum prostate specific antigen measurement and digital rectal examination. We recommended biopsy when either test was suspicious.
RESULTS: Black men had a higher prevalence of elevated prostate specific antigen (13.1 versus 8.9%) and cancer (5.1 versus 3.2%) than white men, and a higher prevalence of clinically but not pathologically advanced cancer. Fewer black men in lower income zip codes complied with recommendations for biopsy.
CONCLUSIONS: In our screening study black men had a higher prevalence of detectable cancer. However, unlike in clinical studies there was no striking racial difference in advanced cancer stage at diagnosis.

Entities:  

Mesh:

Year:  1996        PMID: 8808873

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Prostate Cancer Education, Detection, and Follow-Up in a Community-Based Multiethnic Cohort of Medically Underserved Men.

Authors:  Omotola S Ashorobi; Jacqueline Frost; Xuemei Wang; Pamela Roberson; E Lin; Robert J Volk; David S Lopez; Lovell A Jones; Curtis A Pettaway
Journal:  Am J Mens Health       Date:  2016-07-08

2.  Cancer Progress and Priorities: Prostate Cancer.

Authors:  Kevin H Kensler; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02       Impact factor: 4.254

3.  BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER IN AFRICANS AND AFRICANS IN THE DIASPORA.

Authors:  E D Yeboah; Ann W Hsing
Journal:  J West Afr Coll Surg       Date:  2016 Oct-Dec

Review 4.  Prostate Cancer Disparities by Race and Ethnicity: From Nucleotide to Neighborhood.

Authors:  Timothy R Rebbeck
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

5.  Predictors of PSA Screening Among Men Over 40 Years of Age Who Had Ever Heard about PSA.

Authors:  Hyung Seok Seo; Nam Kyu Lee
Journal:  Korean J Urol       Date:  2010-06-21

6.  High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer.

Authors:  Ann W Hsing; Edward Yeboah; Richard Biritwum; Yao Tettey; Angelo M De Marzo; Andrew Adjei; George J Netto; Kai Yu; Yan Li; Anand P Chokkalingam; Lisa W Chu; David Chia; Alan Partin; Ian M Thompson; Sabah M Quraishi; Shelley Niwa; Robert Tarone; Robert N Hoover
Journal:  J Urol       Date:  2014-04-18       Impact factor: 7.450

7.  Meta-analyses of methylation markers for prostate cancer.

Authors:  Danjie Jiang; Yusheng Shen; Dongjun Dai; Yan Xu; Chunjing Xu; Huangkai Zhu; Tao Huang; Shiwei Duan
Journal:  Tumour Biol       Date:  2014-07-23

8.  PREVALENCE OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER IN AFRICANS AND AFRICANS IN THE DIASPORA.

Authors:  E D Yeboah
Journal:  J West Afr Coll Surg       Date:  2016 Oct-Dec

Review 9.  Screening for prostate cancer in African Americans.

Authors:  J W Moul
Journal:  Curr Urol Rep       Date:  2000-05       Impact factor: 2.862

10.  Contemporary Radiation Treatment of Prostate Cancer in Africa: A Ghanaian Experience.

Authors:  Francis A Asamoah; Joel Yarney; Shivanshu Awasthi; Verna Vanderpuye; Puja S Venkat; Angelina K Fink; Arash O Naghavi; Afua Abrahams; James E Mensah; Evans Sasu; Samuel N A Tagoe; Peter A S Johnstone; Kosj Yamoah
Journal:  J Glob Oncol       Date:  2018-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.